NASDAQ:QTRX

Quanterix (QTRX) Stock Price, News & Analysis

Quanterix logo
$2.07 -0.79 (-27.62%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$2.08 +0.02 (+0.72%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Quanterix Stock (NASDAQ:QTRX)

Advanced

Key Stats

Today's Range
$2.05
▼
$2.59
50-Day Range
$2.07
▼
$3.81
52-Week Range
$2.05
▼
$8.77
Volume
3.54 million shs
Average Volume
501,148 shs
Market Capitalization
$98.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Reduce

Company Overview

Quanterix Corporation develops technologies for measuring biomarkers in biological samples. Its Simoa (Single Molecule Array) platform is designed to detect proteins and other biomarkers at very low concentrations, supporting research in areas such as neurology, oncology, immunology and cardiovascular disease.

The company provides laboratory instruments, assay kits, consumables and related services. Its products are used by pharmaceutical and biotechnology companies, academic institutions and laboratories to study disease biology and evaluate potential biomarkers in samples such as blood and cerebrospinal fluid.

Founded in 2007 and based in Billerica, Massachusetts, Quanterix serves customers in the United States and internationally. Its technologies are primarily intended to support research and development rather than serve as standalone diagnostic tests.

AI Generated. May Contain Errors.

Quanterix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

QTRX MarketRank™: 
1.65390924002 of 5 stars

Quanterix scored higher than 33% of companies evaluated by MarketBeat, and ranked 1437th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Quanterix has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Quanterix has a consensus price target of $3.50, representing about 69.1% upside from its current price of $2.07.

  • Amount of Analyst Coverage

    Quanterix has only been the subject of 2 research reports in the past 90 days.

  • Read more about Quanterix's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Quanterix has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.80% of the float of Quanterix has been sold short.
  • Short Interest Ratio / Days to Cover

    Quanterix has a short interest ratio ("days to cover") of 10.74, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Quanterix has recently decreased by 2.47%, indicating that investor sentiment is improving.
  • Dividend Yield

    Quanterix does not currently pay a dividend.

  • Dividend Growth

    Quanterix does not have a long track record of dividend growth.

  • News Sentiment

    Quanterix has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Quanterix this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Quanterix to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Quanterix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.50% of the stock of Quanterix is held by insiders.

  • Percentage Held by Institutions

    86.48% of the stock of Quanterix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Quanterix's insider trading history.
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QTRX Stock News Headlines

Quanterix Announces Leadership Transition Plan
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Quanterix (QTRX) & Its Competitors Head-To-Head Review
See More Headlines

QTRX Stock Analysis - Frequently Asked Questions

Quanterix's stock was trading at $6.36 at the beginning of 2026. Since then, QTRX stock has decreased by 67.5% and is now trading at $2.07.

Quanterix Corporation (NASDAQ:QTRX) issued its earnings results on Monday, November, 9th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.42) by $0.04. The company earned $34.97 million during the quarter, compared to the consensus estimate of $33.85 million. Quanterix had a negative trailing twelve-month return on equity of 30.49% and a negative net margin of 75.05%.
Read the conference call transcript
.

Quanterix (QTRX) raised $64 million in an IPO on Thursday, December 7th 2017. The company issued 4,275,200 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

Quanterix's top institutional investors include First Eagle Investment Management LLC (4.64%), Portolan Capital Management LLC (3.88%), Lionhunter Capital Management LLC (3.63%) and Marshall Wace LLP (2.52%). Insiders that own company stock include David R Walt, William P Donnelly and Benjamin Meadows.
View institutional ownership trends
.

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quanterix investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Intel (INTC), Pfizer (PFE), Teladoc Health (TDOC), Block (XYZ) and Intellia Therapeutics (NTLA).

Company Calendar

Last Earnings
11/09/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:QTRX
CIK
1503274
Fax
N/A
Employees
450
Year Founded
2007

Price Target and Rating

High Price Target
$4.00
Low Price Target
$3.00
Potential Upside/Downside
+69.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$107.15 million
Net Margins
-75.05%
Pretax Margin
-74.66%
Return on Equity
-30.49%
Return on Assets
-22.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.09
Quick Ratio
2.22

Sales & Book Value

Annual Sales
$138.90 million
Price / Sales
0.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.62 per share
Price / Book
0.45

Miscellaneous

Outstanding Shares
47,480,000
Free Float
46,766,000
Market Cap
$98.28 million
Optionable
Optionable
Beta
1.06

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:QTRX) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners